Followers | 14 |
Posts | 1731 |
Boards Moderated | 0 |
Alias Born | 04/07/2014 |
Monday, March 04, 2019 11:36:36 AM
"Decreases in pain and quality of life improvement associated with ActiPatch use also reduced financial burden to the NHS, associated with providing healthcare services. Utilization of healthcare services, such as visits to a General Practitioner (GP), pain specialist and/or other healthcare professionals for example physical therapist, were reduced for the entire study group. Additionally, costs associated with prescription analgesic medications was also reduced by a total of £2960, or £98.66 per subject over a 3-month period.
Conclusion:
Introduction of ActiPatch as a chronic pain therapy resulted in significant improvements in patient quality of life, reduced pain medication use and reduced utilization of healthcare services. Incorporating ActiPatch as a standard therapy option for chronic pain sufferers is expected to result in significant cost savings for the NHS."
Good lord, and BIEL is unable to supply and sell this product?! IMHO, all BIEL needs to do is present these two paragraphs in a slick Ad formula, and their troubles are over, overnight! Why this product is not supplied and flying off the selves by now, is an unqualified mystery to me! This is absurd! Something is seriously wrong here folks!!
GLTA!!!
P.S. A "D" student from a third rate marketing school could be highly successful in selling this product. 100:1 on it!
FEATURED Integrated Ventures Files Q3/2024 With Mining Revenues Of $1,983,250 And Positive Earnings Of $0.05 Cents Per Share • May 15, 2024 10:30 AM
Swifty Global Announces Impressive Financial Results for Q1 2024 • DRCR • May 15, 2024 10:25 AM
Branded Legacy Inc. Invites Shareholders to Celebrate Milestones at Open House: Announces Share Buyback and Commitment to Authorized Share Count • BLEG • May 15, 2024 8:30 AM
Alliance Creative Group (ACGX) Releases Q1 2024 Financial and Disclosure Report with an 88% increase in Net Income from Q1 2023 to Q1 2024 • ACGX • May 15, 2024 8:30 AM
Category V Biotech, Inc. Announces Letter of Intent to Acquire Genetic Networks, Expanding into Biotechnology Sector • CATV • May 15, 2024 8:00 AM
POET Announces Design Win and Collaboration with Foxconn Interconnect Technology for High-speed AI Systems • POET • May 14, 2024 10:09 AM